James River Group Holdings Inc Dossier - Source-backed chat

James River Group Holdings Inc

JRVRNASDAQ

SectorFinancials

IndustryProperty & Casualty Insurance

Beta (adjusted)0.20

Intrinsic Value $8.01median of 2 methodsbased on filings through 30 Jun 2026

Market Price $3.45Price as of 1 Oct 2026

Significantly undervaluedIntrinsic value is 132% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

marker beyond scale (+132%)

Data confidence Sign in to view data confidence

Market Cap $159.6M

Enterprise Value $293.8M

Shares Outstanding 46.2M diluted

Next Earnings Date9 Nov 2026

Last ex-dividend8 Jun 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

James River Group Holdings, Inc. (JRVR) is navigating a complex operational transition following the sale of its reinsurance business (JRG Re) and ongoing underwriting headwinds. The company's Q1 2026 results highlighted a significant net loss driven by a $6.7 million reinsurance reinstatement premium charge and adverse prior-year reserve development, missing consensus EPS estimates by over 57%. While core specialty lines and excess casualty premiums continue to show growth, and the rollout of AI-enabled underwriting technology offers long-term efficiency potential, near-term profitability remains pressured. A neutral 'Hold' stance is warranted as the market awaits clearer signs of an underwriting turnaround and the resolution of ongoing breach-of-contract litigation against Fleming.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets2 analysts · as of 18 Aug 2026

Low · most bearish analyst$4.75

Mean target$5.38

High · most bullish analyst$6.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Base CaseCentral scenario

The company stabilizes its underwriting margins in core E&S lines, supported by continued hard market conditions and rate increases. AI-driven underwriting tools gradually improve expense ratios, and the litigation with Fleming proceeds without further material negative surprises, keeping the stock range-bound with modest recovery potential.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strong wholesale distribution partnerships and premium growth in core Excess and Surplus (E&S) and excess casualty lines.
Implementation of AI-enabled underwriting technology to drive operational efficiency and lower G&A expenses.
Potential financial recovery from ongoing direct breach-of-contract damages claims against Fleming Intermediate Holdings.

Key Investment Risks

Risk of further adverse prior-year reserve development within specialty insurance segments.
Margin compression in casualty lines due to elevated loss ratios and claim severities.
Execution risks associated with the strategic pivot away from reinsurance toward core specialty admitted and E&S lines.

Thesis Invalidation Triggers

Additional material reserve strengthening charges in upcoming quarters.
An unfavorable final court ruling in the Fleming litigation resulting in no financial recovery or additional legal costs.
A downgrade of the financial strength ratings of regulated insurance subsidiaries by A.M. Best below 'A-'.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.